Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans (Q36996713)

17 August 2017

1 reference

title

Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans (English)

1 reference

17 August 2017

Lawrence Agodoa

1

1 reference

PubMed ID

17991208

17 August 2017

Paul Eggers

series ordinal

2

1 reference

17 August 2017

1 November 2007

1 reference

17 August 2017

1 reference

17 August 2017

20

1 reference

17 August 2017

6

1 reference

17 August 2017

577-585

1 reference

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

17 August 2017

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2007.00350.X

Race and sex differences in the identification of candidates for renal transplantation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2007.00350.X

Mortality and optimal body mass index in a sample of the US population

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2007.00350.X

The effect of patients' preferences on racial differences in access to renal transplantation

21 January 2018

2 references

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1056/NEJM199911253412206

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Barriers to cadaveric renal transplantation among blacks, women, and the poor

2 references

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1001/JAMA.280.13.1148

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Racial Differences in the Progression from Chronic Renal Insufficiency to End-Stage Renal Disease in the United States

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Simple nutritional indicators as independent predictors of mortality in hemodialysis patients.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Prospective analysis of global costs for maintenance of patients with ESRD.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

HIV-associated nephropathy

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Cocaine use, hypertension, and end-stage renal disease

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse?

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Racial factors in the incidence and causation of end-stage renal disease (ESRD).

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Association between serum lipids and survival in hemodialysis patients and impact of race

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Is there an epidemic of HIV Infection in the US ESRD program?

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Early referral and its impact on emergent first dialyses, health care costs, and outcome

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

To have and have not: Health and health care disparities in chronic kidney disease

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Dose of hemodialysis and survival: differences by race and sex.

2 references

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1001/JAMA.280.20.1764

The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

HIV-associated nephropathy: an urban epidemic

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Analgesic use and chronic renal disease

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Late referral and modality choice in end-stage renal disease

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Effect of dialysis dose and membrane flux in maintenance hemodialysis

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Can progression of autosomal dominant or autosomal recessive polycystic kidney disease be prevented?

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Cocaine use and chronic renal failure

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Survival advantage in Asian American end-stage renal disease patients

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Minimizing racial disparity regarding receipt of a cadaver kidney transplant

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Factors Affecting the Waiting Time of Cadaveric Kidney Transplant Candidates in the United States

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Racial differences in the incidence of treatment for end-stage renal disease

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Delayed referral of black, Hispanic, and older patients with chronic renal failure

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

The dose of hemodialysis and patient mortality

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Autosomal dominant polycystic kidney disease - clinical and genetic aspects

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Racial disparities in access to simultaneous pancreas-kidney transplantation in the United States

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

The impact of comorbid and sociodemographic factors on access to renal transplantation

2 references

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1001/JAMA.1993.03500050081030

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Timing of nephrologist referral and arteriovenous access use: the CHOICE Study.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Determinants of type and timing of initial permanent hemodialysis vascular access

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1525-139X.2007.00350.X

Identifiers

DOI

10.1111/J.1525-139X.2007.00350.X

1 reference

release_i52ywrzu7zas3nvrgznalep6v4

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i52ywrzu7zas3nvrgznalep6v4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

17991208

1 reference

PubMed ID

17991208